TP53 and lung carcinoma: Regardless of p53 function, the tumor-promoting consequence is still largely promoted in A549 (p53 wild-type) lung cancer cells with a constitutive activation of MCT-1 (Figure 5D), further revealing that MCT-1 oncogenicity could overcome p53 action in the tumor development.